Devices › Device types
FDA product code GIM · class 2 · Clinical Chemistry
Tubes, vacuum sample, with anticoagulant: medical device reports filed with FDA
2,002 reports carry this product code, 1999–2026; 15 brands with a page.
- 2,002
- reports with this product code
- 0% of all MAUDE reports
- 521
- reports, 12 months to August 2026
- 578 in the 12 months before
- 99.6%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code GIM is FDA's classification for "Tubes, vacuum sample, with anticoagulant" (clinical Chemistry panel), a class 2 device. 2,002 medical device reports carry this product code, 0% of the MAUDE database, from April 1999 to August 2026.
521 reports arrived in the 12 months to August 2026, down 10% from 578 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.6%) and injury (0.3%). 15 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| BD Vacutainer K2 EDTA (K2E) 5.4mg Blood Collection Tubes | 427 | 173 | 0% | 99.6% |
| BD Vacutainer K2 EDTA (K2E) 3.6mg Blood Collection Tubes | 401 | 103 | 0% | 100% |
| BD Vacutainer K2 EDTA (K2E) 7.2mg Blood Collection Tubes | 185 | 103 | 0% | 99.6% |
| BD MiniDraw H&H Capillary Blood Collection Tube | 156 | 76 | 0% | 100% |
| BD Vacutainer K2 EDTA (K2E) 10.8mg Blood Collection Tubes | 141 | 25 | 0% | 99.3% |
| Bd Vacutainer K2 Edta K2e Blood Collection Tubes | 56 | 0 | 0% | 100% |
| Bd Vacutainer K2 Edta K2e Plus Blood Collection Tubes | 40 | 15 | 0% | 100% |
| BD Vacutainer PST Gel and Lithium HeparinN 56 Units | 6 | 55 | 0% | 99.4% |
| BD Vacutainer EDTA 2K | 2 | 53 | 0.1% | 99.9% |
| Bd Vacutainer 9nc 0 129m Plus Blood Collection Tubes | 1 | 12 | 0% | 100% |
| Bd Vacutainer Buffered Sodium Citrate 9nc Blood Collection Tube | 1 | 1 | 0% | 100% |
| BD Vacutainer K3E 5.4mg Plus Blood Collection Tubes | 1 | 23 | 0% | 99.5% |
| BD Vacutainer PPT Plasma Preparation Tube K2E 9.0 mg | 1 | 56 | 0% | 100% |
| Bd Vacutainer Precisionglide Multiple Sample Needle | 1 | 0 | 0% | 98.6% |
| BD Vacutainer Serum Blood Collection Tubes | 1 | 119 | 0% | 99.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Becton Dickinson & Broken Bow | 857 | 42.8% |
| Becton Dickinson & Franklin Lakes | 326 | 16.3% |
| Becton Dickinson | 256 | 12.8% |
| Bd Caribe | 113 | 5.6% |
| Becton Dickinson And Bd | 67 | 3.3% |
| Becton Dickinson And | 3 | 0.1% |
| Becton Dickinson & Bd | 2 | 0.1% |
| International Technidyne | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Short fill | 652 | 32.6% |
| Device contamination with chemical or other material | 301 | 15% |
| Leak/splashthe device leaked | 203 | 10.1% |
| Coagulation in device or device ingredient | 183 | 9.1% |
| Volume accuracy problem | 112 | 5.6% |
| Improper chemical reaction | 86 | 4.3% |
| Incorrect, inadequate or imprecise result or readings | 77 | 3.8% |
| Device markings/labelling problema problem with the device markings or label | 61 | 3% |
| Material protrusion/extrusion | 59 | 2.9% |
| Clumping in device or device ingredient | 54 | 2.7% |
| Material deformation | 49 | 2.4% |
| Incorrect or inadequate test results | 40 | 2% |
| Premature separation | 37 | 1.8% |
| Filling problem | 36 | 1.8% |
| Device ingredient or reagent problem | 34 | 1.7% |
| Difficult to insertthe device was hard to insert | 31 | 1.5% |
| Excessive heating | 31 | 1.5% |
| Crackthe device cracked | 22 | 1.1% |
| Fluid/blood leak | 22 | 1.1% |
| Overfill | 20 | 1% |
Questions about tubes, vacuum sample, with anticoagulant reports
What is product code GIM?
FDA's classification code for "Tubes, vacuum sample, with anticoagulant", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,002 reports through August 2026, 521 of them in the latest 12 months.
Which brands appear most often?
BD Vacutainer K2 EDTA (K2E) 5.4mg Blood Collection Tubes (427), BD Vacutainer K2 EDTA (K2E) 3.6mg Blood Collection Tubes (401), BD Vacutainer K2 EDTA (K2E) 7.2mg Blood Collection Tubes (185), BD MiniDraw H&H Capillary Blood Collection Tube (156) and BD Vacutainer K2 EDTA (K2E) 10.8mg Blood Collection Tubes (141). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.